BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 22917985)

  • 1. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
    Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
    Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
    Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
    BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
    Burger M; Oosterlinck W; Konety B; Chang S; Gudjonsson S; Pruthi R; Soloway M; Solsona E; Sved P; Babjuk M; Brausi MA; Cheng C; Comperat E; Dinney C; Otto W; Shah J; Thürof J; Witjes JA;
    Eur Urol; 2013 Jan; 63(1):36-44. PubMed ID: 22981672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simultaneous robot-assisted laparoscopic cystectomy and laparoscopic nephrectomy: first experience on 3 patients with short-term follow-up].
    Peter J; May M; Ahmed AM; Ahmed A; Gilfrich C
    Aktuelle Urol; 2012 Jul; 43(4):255-61. PubMed ID: 22869496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications.
    Challacombe BJ; Bochner BH; Dasgupta P; Gill I; Guru K; Herr H; Mottrie A; Pruthi R; Redorta JP; Wiklund P
    Eur Urol; 2011 Oct; 60(4):767-75. PubMed ID: 21620562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes.
    Desai MM; Berger AK; Brandina RR; Zehnder P; Simmons M; Aron M; Skinner EC; Gill IS
    Eur Urol; 2012 Feb; 61(2):350-5. PubMed ID: 22036642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature.
    Soukup V; Babjuk M; Bellmunt J; Dalbagni G; Giannarini G; Hakenberg OW; Herr H; Lechevallier E; Ribal MJ
    Eur Urol; 2012 Aug; 62(2):290-302. PubMed ID: 22609313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases.
    Hrbáček J; Macek P; Ali-El-Dein B; Thalmann GN; Stenzl A; Babjuk M; Shaaban AA; Gakis G
    Urol Int; 2015; 94(1):45-9. PubMed ID: 25171129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion.
    Hautmann RE; Abol-Enein H; Davidsson T; Gudjonsson S; Hautmann SH; Holm HV; Lee CT; Liedberg F; Madersbacher S; Manoharan M; Mansson W; Mills RD; Penson DF; Skinner EC; Stein R; Studer UE; Thueroff JW; Turner WH; Volkmer BG; Xu A;
    Eur Urol; 2013 Jan; 63(1):67-80. PubMed ID: 22995974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
    Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
    Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy.
    Iwai A; Koga F; Fujii Y; Masuda H; Saito K; Numao N; Sakura M; Kawakami S; Kihara K
    Jpn J Clin Oncol; 2011 Dec; 41(12):1373-9. PubMed ID: 21994208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
    Nuhn P; Bastian PJ; Novara G; Svatek RS; Karakiewicz PI; Skinner E; Fradet Y; Izawa JI; Kassouf W; Montorsi F; Müller SC; Fritsche HM; Sonpavde G; Tilki D; Isbarn H; Ficarra V; Dinney CP; Shariat SF
    Urol Int; 2011; 87(1):42-8. PubMed ID: 21659717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].
    Stenzl A; Cowan NC; De Santis M; Jakse G; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Actas Urol Esp; 2010 Jan; 34(1):51-62. PubMed ID: 20223133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
    Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
    BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.
    Jonsson MN; Adding LC; Hosseini A; Schumacher MC; Volz D; Nilsson A; Carlsson S; Wiklund NP
    Eur Urol; 2011 Nov; 60(5):1066-73. PubMed ID: 21852033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    Veskimäe E; Neuzillet Y; Rouanne M; MacLennan S; Lam TBL; Yuan Y; Compérat E; Cowan NC; Gakis G; van der Heijden AG; Ribal MJ; Witjes JA; Lebrét T
    BJU Int; 2017 Jul; 120(1):12-24. PubMed ID: 28220653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.